Labocanna Spolka Akcyjna
LCN | WAR
Overview
Corporate Details
- ISIN(s):
- PLCCTLS00017 (+1 more)
- LEI:
- 259400GAPNZTGIR9PK55
- Country:
- Poland
- Address:
- KOSZALIN MIESZKA I 49, 75-129 KOSZALIN
- Website:
- http://www.labocanna.pl
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Labocanna Spolka Akcyjna is at the forefront of the cannabis and wellness industry, specializing in the production of high-quality cannabis-based products. The company is dedicated to advancing research and development to create effective and safe wellness solutions. Labocanna’s commitment to innovation and compliance with regulatory standards has established it as a trusted name in the growing cannabis market. It aims to promote well-being through its diverse range of health-focused products.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-02-09 17:33 |
Regulatory News Service
Zawarcie przedwstępnej umowy na import marihuany medycznej - Content (PL)
|
Polish | 2.3 KB | |
| 2024-02-09 08:40 |
M&A Activity
Rozwiązanie Umowy Inwestycyjnej w sprawie połączenia ze spółką Foxbuy.com S.A. …
|
Polish | 806 bytes | |
| 2024-01-24 17:56 |
Declaration of Voting Results & Voting Rights Announcements
Lista akcjonariuszy, którzy wzięli udział w Walnym Zgromadzeniu oraz mieli co n…
|
Polish | 810 bytes | |
| 2024-01-18 08:46 |
Regulatory News Service
Otrzymanie pisma z Instytutu Weterynaryjnego - Państwowego Instytutu Badawczego…
|
Polish | 874 bytes | |
| 2024-01-02 17:24 |
Regulatory News Service
Wygaśnięcie umowy o zachowaniu poufności - Content (PL)
|
Polish | 654 bytes | |
| 2023-12-28 17:28 |
Proxy Solicitation & Information Statement
Formularz dla pełnomocnika
|
Polish | 133.8 KB | |
| 2023-12-28 17:28 |
Pre-Annual General Meeting Information
Proponowane zmiany statutu Labocanna S.A.
|
Polish | 183.6 KB | |
| 2023-12-28 17:28 |
Pre-Annual General Meeting Information
Projekty uchwał na NWZA Labocanna S.A.
|
Polish | 221.4 KB | |
| 2023-12-28 17:28 |
Pre-Annual General Meeting Information
Ogłoszenie o NWZA Labocanna S.A.
|
Polish | 99.3 KB | |
| 2023-12-28 17:28 |
Pre-Annual General Meeting Information
ogłoszenie o zwołaniu NWZ na dzień 24 stycznia 2024 r. wraz z projektami uchwał…
|
Polish | 469 bytes | |
| 2023-12-28 16:49 |
Major Shareholding Notification
Lista akcjonariuszy, którzy wzięli udział w Walnym Zgromadzeniu oraz mieli co n…
|
Polish | 603 bytes | |
| 2023-12-20 18:02 |
Share Issue/Capital Change
Założenie spółki zależnej - Content (PL)
|
Polish | 1.0 KB | |
| 2023-12-01 15:37 |
Proxy Solicitation & Information Statement
Formularz dla pełnomocnika na NWZA
|
Polish | 132.6 KB | |
| 2023-12-01 15:37 |
Registration Form
Proponowane zmiany statutu na NWZA
|
Polish | 204.9 KB | |
| 2023-12-01 15:37 |
Post-Annual General Meeting Information
Projekty uchwła na NWZA
|
Polish | 246.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Cuorips Inc. | Japan | 4894 | |
|
Cyfuse Biomedical K.K. | Japan | 4892 | |
|
DAIICHI SANKYO COMPANY, LIMITED | Japan | 4568 | |
|
Daito Pharmaceutical Co., Ltd. | Japan | 4577 | |
|
DanCann Pharma A/S | Denmark | DANCAN | |
|
DARWIN AG | Germany | 7V0 | |
|
Dechra Pharmaceuticals PLC | United Kingdom | DPH | |
|
Delta-Fly Pharma, Inc. | Japan | 4598 | |
|
Dermapharm Holding SE | Germany | DMP | |
|
Dicot Pharma AB | Sweden | DICOTBT |